ArticlePDF Available

Variants of the Melanocyte-Stimulating Hormone-Receptor Gene Are Associated with Red Hair and Fair Skin in Humans

Authors:
  • Paloma Valverde Consulting, LLC

Abstract

Melanin pigmentation protects the skin from the damaging effects of ultraviolet radiation (UVR). There are two types of melanin, the red phaeomelanin and the black eumelanin, both of which are present in human skin. Eumelanin is photoprotective whereas phaeomelanin, because of its potential to generate free radicals in response to UVR, may contribute to UV-induced skin damage. Individuals with red hair have a predominance of phaeomelain in hair and skin and/or a reduced ability to produce eumelanin, which may explain why they fail to tan and are at risk from UVR. In mammals the relative proportions of phaeomelanin and eumelanin are regulated by melanocyte stimulating hormone (MSH), which acts via its receptor (MC1R), on melanocytes, to increase the synthesis of eumelanin and the product of the agouti locus which antagonises this action. In mice, mutations at either the MC1R gene or agouti affect the pattern of melanogenesis resulting in changes in coat colour. We now report the presence of MC1R gene sequence variants in humans. These were found in over 80% of individuals with red hair and/or fair skin that tans poorly but in fewer than 20% of individuals with brown or black hair and in less than 4% of those who showed a good tanning response. Our findings suggest that in humans, as in other mammals, the MC1R is a control point in the regulation of pigmentation phenotype and, more importantly, that variations in this protein are associated with a poor tanning response.
© 1995 Nature Publishing Group http://www.nature.com/naturegenetics
© 1995 Nature Publishing Group http://www.nature.com/naturegenetics
© 1995 Nature Publishing Group http://www.nature.com/naturegenetics
... The investigation of SNPs associated with skin color began in the late 1990s and early 2000s [5][6][7]. Although interest in using SNPs to predict physical traits emerged in the early 2000s, it did not gain significant traction until the end of that decade [8]. ...
... The MC1R gene is among the most extensively studied genes in relation to pigmentation. Variations within this gene have been shown to correlate with lighter skin and hair colors, particularly in European populations [5]. ...
Article
Full-text available
Forensic DNA phenotyping (FDP) has emerged as an essential tool in criminal investigations, enabling the prediction of physical traits based on genetic information. This review explores the genetic factors influencing skin pigmentation, particularly within Asian populations, with a focus on Thailand. Key genes such as Oculocutaneous Albinism II (OCA2), Dopachrome Tautomerase (DCT), KIT Ligand (KITLG), and Solute Carrier Family 24 Member 2 (SLC24A2) are examined for their roles in melanin production and variations that lead to different skin tones. The OCA2 gene is highlighted for its role in transporting ions that help stabilize melanosomes, while specific variants in the DCT gene, including single nucleotide polymorphisms (SNPs) rs2031526 and rs3782974, are discussed for their potential effects on pigmentation in Asian groups. The KITLG gene, crucial for developing melanocytes, includes the SNP rs642742, which is linked to lighter skin in East Asians. Additionally, recent findings on the SLC24A2 gene are presented, emphasizing its connection to pigmentation through calcium regulation in melanin production. Finally, the review addresses the ethical considerations of using FDP in Thailand, where advances in genetic profiling raise concerns about privacy, consent, and discrimination. Establishing clear guidelines is vital to balancing the benefits of forensic DNA applications with the protection of individual rights.
... Theoretically, for the selective destruction of a target, the laser energy must be at a wavelength that is highly absorbed by the target relative to the surrounding tissue, and the pulse duration must be shorter than the time required for heat to dissipate through conduction [22]. Furthermore, based on the theory of stress relaxation time, the shorter the pulse duration, the more likely the primary response is to involve photomechanical disruption rather than photothermal effects [23]. The effectiveness of continuous use of 755-nm alexandrite and/or 1064-nm neodymium: yttrium aluminum garnet lasers has been reported for ADM treatment, but the appropriate wavelength has not been fully discussed [20]. ...
Article
Full-text available
Background Acquired dermal melanocytosis (ADM) is a pigmentary lesion caused by melanocytes in the dermis. These conditions are refractory, and a consensus on treatment remains elusive. Aims To compare the efficacy of 730‐ and 1064‐nm picosecond lasers in the treatment of ADM and to supplement the comparison with a literature review. Patients: We retrospectively examined patients who underwent picosecond laser therapy between April 2021 and February 2024. Treatments were performed three times with spot irradiation using a 730‐nm laser (3‐mm spot, 1.7–1.8 J/cm²; or 2‐mm spot, 2.5–3.25 J/cm²) and a 1064‐nm laser (3‐mm spot, 3.1–4.0 J/cm²). Two months after each procedure, patient satisfaction was evaluated using questionnaires, macroscopic findings were assessed using photographs, and melanin accumulation was analyzed using skin analysis software. Evaluations were conducted on a 4‐point scale (excellent, good, fair, and poor), with good or higher considered effective. Results Seventy‐eight and 83 patients were assigned to the 730‐ and 1064‐nm groups, respectively. After three sessions, the 730‐nm group exhibited superior outcomes in terms of subjective symptoms (patient satisfaction), objective findings, and software analysis improvements. The incidence of hyperpigmentation was 15.4% in the 1064‐nm group and 14.5% in the 730‐nm group, with no significant differences observed in the rates of other complications. Conclusions The use of a 730‐nm picosecond laser, which possesses high melanin selectivity, relatively deep penetration, and a short pulse width, suggests a potentially more effective treatment for ADM, compared to the effects of the conventional 1064‐nm wavelength, without increasing complications.
... Alpha-melanocyte-stimulating hormone (α-MSH) is a tridecapeptide derived from its precursor hormone proopiomelanocortin (POMC) and is the most important melanocyte-stimulating hormone (MSH), also known as melanotropin, that stimulates melanogenesis, a process primarily responsible for the pigmentation of hair and skin in mammals (including humans) [1,2]. The melanocortin system includes the ligands α-, β-, and γ-MSH, as well as adrenocorticotropic hormone (ACTH), all of which share a central sequence His-Phe-Arg-Trp (HFRW) as a common pharmacophore. ...
Article
Full-text available
Background Alpha-melanocyte-stimulating-hormone (α-MSH) has been identified as a new anti-inflammatory treatment compound in rheumatoid arthritis (RA) and other inflammatory diseases. However, its direct effect on bone cell differentiation or on bone regeneration, which is an inflammatory process, too, has not been investigated, yet. Bone tissue is significantly affected in inflammatory joint diseases. Additionally, inflammatory signaling is essential -in bone regeneration during fracture healing. Therefore, we evaluated the impact of α-MSH-treatment on bone forming cells in an inflammatory setting in vitro and as a treatment approach in a murine fracture healing model in vivo. Methods The influence of α-MSH treatment and melanocortin-receptor expression patterns was investigated in vitro in the presence of either IL-1β or/and TNF-α as an inflammatory stimulus. Osteoblast cell function was evaluated by analyzing proliferation and mineralisation capacities. Using quantitative real time PCR, we analyzed mRNA expression of receptors. To explore the impact of α-MSH on bone regeneration in vivo, treatment with α-MSH or NaCl (control) was performed in a murine fracture-healing model using a closed femur fracture stabilized with an intramedullary implant (female, n = 6–8 mice per group). Results α-MSH-treatment did not impair either proliferation nor mineralisation of osteoblastic cells under native or inflammatory conditions (no significant differences found). All four melanocortin receptor-molecules were expressed in murine osteoblastic cells but in very limited amounts and this did not change upon treatment with inflammatory cytokines or α-MSH or both at the same time. Callus formation in fractured femurs of α-MSH-treated mice was slightly delayed at day 14 post fracture with regard to less cartilage formation (NaCl: 19.9%; α-MSH: 13.5%) and soft tissue remodeling (NaCl: 15.2%; α-MSH: 19.5%) but these results were not significantly different and fracture healing overall occurred in a regular way. Conclusion α-MSH has no negative impact on bone or bone-forming cells in native, inflammatory, or regenerative contexts. We can conclude from our results, that treatment of inflammatory diseases using α-MSH does not interfere significantly with bone regeneration in a murine fracture model and therefore treatment with α-MSH could be continued without negative effects on bone formation and bone regeneration in patients. Clinical trial number Not applicable.
... Another gene that has been associated with an increased risk of developing melanoma is melanocortin 1 receptor (MC1R), which is highly polymorphic in the Caucasian population [26]. Several MC1R loss-of-function germline variant alleles have been associated with red hair, fair skin and freckling, which fail to stimulate cAMP production in response to α-MSH signaling to induce melanin production [27,28]. ...
Article
Full-text available
Melanoma is a highly aggressive type of skin cancer. Metastatic melanoma tumors have historically featured a particularly poor prognosis and have often been considered incurable. Recent advances in targeted therapeutic interventions have radically changed the landscape in metastatic melanoma management, significantly increasing the overall survival of patients. Hyperactive BRAF is the most common mutational event found in metastatic melanoma and its inhibition has proven to be a successful approach in a number of patients. Unfortunately, initial tumor retreat is followed by relapse in most cases, highlighting the elusiveness of finding a widely effective treatment. Melanoma tumors often carry a particularly high number of mutations in what is known as a high level of inter- and intra-patient tumor heterogeneity, driving resistance to treatment. The various mutations that are present in these tumors, in addition to impacting the root cause of the malignancy and the potential for therapeutic interventions, have also been known to arise during tumor clonal evolution leading to the establishment of drug resistance, a major issue in melanoma management.
Chapter
Exploring the complex world of hair color, this chapter explains the underlying molecular mechanisms and genetic factors that give rise to the various shades of human hair. The exploration begins with a comprehensive analysis of the molecular processes that control the synthesis of eumelanin and pheomelanin, the pigments that give hair its color, is undertaken. An understanding of the fundamental biochemical pathways involved is provided by the elucidation of the complex processes of melanogenesis, which include the biosynthesis and regulation of each pigment. Subsequently, the emphasis turns to the regulatory factors that impact melanogenesis, specifically highlighting the crucial roles of key players in this complex process. Knowledge about the regulatory processes that transporters like cystinosin and Na/H exchangers orchestrate is presented, providing light on how these mechanisms affect the dynamic equilibrium of pigmentation. The exploration extends into the genetic landscape of hair color, focusing on the melanocortin 1 receptor (MC1R) gene. The function of various MC1R variants in the control of pigmentation and phenotypic expression is investigated, offering a detailed knowledge of the genetic factors influencing individual hair color. The chapter concludes by delving into the field of genome-wide association studies (GWAS), which are an effective means of revealing the intricate genetic foundations of hair color. This chapter provides a comprehensive understanding of the genetics and molecular mechanisms underlying the fascinating diversity of human hair color by fusing molecular insights with genetic factors.
Article
Full-text available
We have identified a second Drosophila opsin gene, Rh4, which is expressed specifically in the ultraviolet-sensitive R7 photoreceptor cells. The two R7 opsins, Rh3 and Rh4, are expressed in nonoverlapping subsets of R7 cells. The Rh4 opsin shares 72% amino acid identity with Rh3, but is only about 35% homologous with the other 2 Drosophila opsins, ninaE and Rh2. Twenty-eight amino acids are conserved among all 4 invertebrate and 5 vertebrate opsin genes thus far sequenced, suggesting that these residues play an important role in rhodopsin function.
Article
Full-text available
We have used two techniques to isolate and characterize eye-specific genes from Drosophila melanogaster. First, we identified genes whose expression is limited to eyes, photoreceptor cells, or R7 photoreceptor cells by differential screening with [32P]cDNAs derived from the heads of mutant flies that have reduced amounts of these tissues and cells (Microcephalus, glass3, and sevenless, respectively). Secondly, we identified opsin genes by hybridization with synthetic [32P]oligonucleotides that encode domains that have been conserved between some opsin genes. We found seven clones that contain genes expressed only in the eye or optic lobes of Drosophila; three are expressed only in photoreceptor cells. One is expressed only in R7 photoreceptor cells and hybridizes to some of the previously mentioned oligonucleotides. The complete DNA sequence of the R7-specific opsin gene and its 5' and 3' flanking regions was determined. It is quite different from other known Drosophila opsin genes, in that it is not interrupted by introns and shares only 37-38% amino acid identity with the proteins encoded by these genes. The predicted protein structure contains many characteristics that are common to all rhodopsins, and the sequence differences help to identify four domains of the rhodopsin molecule that have been conserved in evolution.
Article
In mammals, melanin exists in two chemically distinct forms: the red-yellow phaeomelanin and the brown-black eumelanin. Although administration of the pigmentary hormone α-melanocyte-stimulating hormone (αMSH) and its synthetic analogue Nle4DPhe7αMSH induces skin darkening in man, the increases in melanogenesis in cultured human melanocytes in response to these peptides are relatively small, However, it is possible that MSH affects the eumelanin:phaeomelanin ratio rather titan total cellular melanin. Thus, this study examined the specific effects of Nle4DPhe7αMSH on the two melanins in cultured human melanocytes, quantifying eumelanin and phaeomelanin by hign performance liquid chromatography. Nle4DPhe7αMSH induced significant increases in the eumelanin content of these cells while having lesser and varied effects on the levels of phaeomelanin. As a consequences the eumelanin: phaeomelanin ratio was increased in every culture. These results demonstrate that Nle4DPhe7αMSH affects melanin type in human melanocytes and suggest a possible mechanism by which this peptide induces skin darkening in man.
Article
GnRH plays a pivotal role in the reproductive system, and GnRH analogs have wide therapeutic applications ranging from the treatment of prostatic cancer to infertility. Determination of the predicted structure of the GnRH receptor (GnRHR) would illuminate the mechanisms of receptor activation and regulation and allow directed design of improved GnRH analogs. We report the cloning of a cDNA representing the mouse GnRHR and confirm its identity using Xenopus oocyte expression. Injection of sense RNA transcript leads to the expression of a functional, high affinity GnRHR. Expression of the GnRHR using gonadotrope cell line RNA, however, is blocked by an antisense oligonucleotide. In situ hybridization in the rat anterior pituitary reveals a characteristic GnRHR distribution. The nucleotide sequence encodes a 327-amino acid protein which has the seven putative transmembrane domains characteristic of G protein-coupled receptors, but which lacks a typical intracellular C-terminus. The unusual structure and novel potential regulatory domain of the GnRHR may explain unique aspects of its signal transduction and regulation.
Article
Melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) regulate pigmentation and adrenal cortical function, respectively. These peptides also have a variety of biological activities in other areas, including the brain, the pituitary, and the immune system. A complete understanding of the biological activities of these hormones requires the isolation and characterization of their corresponding receptors. The murine and human MSH receptors (MSH-Rs) and a human ACTH receptor (ACTH-R) were cloned. These receptors define a subfamily of receptors coupled to guanine nucleotide-binding proteins that may include the cannabinoid receptor.
Article
There are two types of melanin in mammals, the brownish black eumelanin and the reddish yellow pheomelanin. Eumelanin and pheomelanin are present in human hair and this study was carried out to see whether both pigments are also present in human epidermis. Samples of epidermis were obtained from suction blisters raised in the upper arm of 13 Caucasian subjects of skin types I, II, and III and analyzed for both eumelanin and pheomelanin using a procedure involving high-performance liquid chromatography. Eumelanin and pheomelanin were found in all epidermal samples and their relative proportions correlated well with those found in samples of hair taken from the same subjects. The lowest concentrations of eumelanin were found in subjects of skin type I, with higher levels in skin types II and III. The concentrations of pheomelanin were more variable and showed no relationship to skin type. Increases in the concentrations of both pigments occurred following PUVA therapy, but whereas the largest increases in eumelanin were seen in skin types II and III, the increases in pheomelanin showed little relationship to skin type. Unlike eumelanin, epidermal pheomelanin also showed little relationship to PUVA-induced tanning. The present findings could be particularly significant in view of recent suggestions that pheomelanin, rather than protecting the skin against UV radiation, may actually contribute to UV-induced skin damage.
Article
Pheomelanin from human red hair (RHM) produces considerably more cellular damage in Ehrlich ascites carcinoma cells when subjected to radiations of wavelength 320-700 nm than eumelanin from black hair (BHM). Irradiation of RHM generated large amounts of superoxide while BHM did not produce detectable amounts of superoxide. The present investigations describe the effects of irradiation of mast cells in the presence of various natural and synthetic melanins. Irradiation of mast cells in the presence of RHM and red hair melanoprotein released large amounts of histamine while BHM and synthetic melanins prepared from dopa, cysteinyldopa, or a mixture of dopa and cysteinyldopa did not release histamine. The release of histamine at lower concentrations of RHM was not accompanied by the release of 51Cr from chromium-loaded cells, suggesting that this release was of noncytotoxic nature. On the other hand, the release of histamine at higher concentrations of RHM was due to cell lysis since both histamine and cytoplasmic marker 51Cr were released to the same extent. The release evoked by large concentration RHM was not inhibited by superoxide dismutase or catalase. This suggests that the cell lysis under these conditions was not due to H2O2 or O-2. The finding that mast cells release histamine when irradiated in the presence of RHM suggests that the immediate and late-phase reactions seen in sunburn may in part be due to the release of mediators from these cells.